Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic Factors of Hyaluronic Acid in Rotator Cuff Disorder
NCT03677895Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Oct 2018
- Primary completion
- Mar 2019
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of hyaluronic acid in rotator cuff disease, sponsored by Taipei Veterans General Hospital. Primary endpoint: Constant Shoulder Score at 12 weeks. Status: unknown.
02
Drugs
hyaluronic acid
03
Conditions
rotator cuff disease
Beyond the preview
Go deeper on NCT03677895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677895.